These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24800254)

  • 21. Pathophysiology of contrast medium-induced nephropathy.
    Persson PB; Hansell P; Liss P
    Kidney Int; 2005 Jul; 68(1):14-22. PubMed ID: 15954892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
    Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats.
    Ladwig M; Flemming B; Seeliger E; Sargsyan L; Persson PB
    Invest Radiol; 2011 Nov; 46(11):672-7. PubMed ID: 21623210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast medium-induced nephropathy: the pathophysiology.
    Persson PB; Tepel M
    Kidney Int Suppl; 2006 Apr; (100):S8-10. PubMed ID: 16612403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-Induced Nephropathy: An "All or None" Phenomenon?
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Angiology; 2015 Jul; 66(6):508-13. PubMed ID: 25225196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast Media-Different Types of Contrast Media, Their History, Chemical Properties, and Relative Nephrotoxicity.
    Lohani S; Rudnick MR
    Interv Cardiol Clin; 2020 Jul; 9(3):279-292. PubMed ID: 32471669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of iso-osmolar contrast use in emergent percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Kanei Y; Ayabe K; Ratcliffe J; Vales L; Nakra N; Friedman P; Fox J
    J Invasive Cardiol; 2011 Nov; 23(11):448-50. PubMed ID: 22045075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis.
    Biondi-Zoccai G; Lotrionte M; Thomsen HS; Romagnoli E; D'Ascenzo F; Giordano A; Frati G
    Int J Cardiol; 2014 Mar; 172(2):375-80. PubMed ID: 24502883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.
    Thomsen HS; Morcos SK
    Eur Radiol; 2009 Apr; 19(4):891-7. PubMed ID: 19002467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrarenal oxygenation by blood oxygenation level-dependent MRI in contrast nephropathy model: effect of the viscosity and dose.
    Li LP; Franklin T; Du H; Papadopoulou-Rosenzweig M; Carbray J; Solomon R; Prasad PV
    J Magn Reson Imaging; 2012 Nov; 36(5):1162-7. PubMed ID: 22826125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
    Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
    Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
    Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
    Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media?
    Downes MO; Nicholson A
    Clin Radiol; 2010 Apr; 65(4):343-4; author reply 344-5. PubMed ID: 20338404
    [No Abstract]   [Full Text] [Related]  

  • 34. Current evidence on prevention and management of contrast-induced nephropathy.
    Thomsen HS
    Eur Radiol; 2007 Dec; 17 Suppl 6():F33-7. PubMed ID: 18376455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
    Fishman EK; Reddan D
    Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The challenges in assessing contrast-induced nephropathy: where are we now?
    Davenport MS; Cohan RH; Khalatbari S; Ellis JH
    AJR Am J Roentgenol; 2014 Apr; 202(4):784-9. PubMed ID: 24660707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonionic contrast media are less nephrotoxic than ionic contrast media to rat renal cortical slices.
    Soejima K; Uozumi J; Kanou T; Fujiyama C; Masaki Z
    Toxicol Lett; 2003 Jun; 143(1):17-25. PubMed ID: 12697376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.
    Benko A; Fraser-Hill M; Magner P; Capusten B; Barrett B; Myers A; Owen RJ;
    Can Assoc Radiol J; 2007 Apr; 58(2):79-87. PubMed ID: 17521052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renal tolerance of iodinated low osmolality contrast agents. Clinical and experimental aspects].
    Deray G; Dubois M; Bellin MF; Grellet J; Jacobs C
    J Radiol; 1990; 71(6-7):439-44. PubMed ID: 2254874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.
    Owen RJ; Hiremath S; Myers A; Fraser-Hill M; Barrett BJ
    Can Assoc Radiol J; 2014 May; 65(2):96-105. PubMed ID: 24559602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.